

Enhancing
Cancer Vaccine Science
for New Therapy Pathways
The CANVAS project - a platform for an in-depth preparation for the therapy of non-small cell lung cancer and an exceptional opportunity for establishing long-term scientific collaboration
research on cell therapy
of non-small cell
lung cancer.


Enhancing
Cancer Vaccine Science
for New Therapy Pathways
News
ICCVS at the EMBO conference 2025
Dr. Artur Pirog represented the ICCVS team at the EMBO conference “Protein Quality Control: From Molecular Mechanisms to Aging and Disease”, held in Hersonissos, Greece (18-23 May 2025). The event brought together researchers from around the world to share the knowledge about proteostasis, the clearance of misfolded proteins, molecular mechanisms of chaperone activity, and novel …
ICCVS Team at 3rd IMMUNO-model COST ACTION Annual Conference
The ICCVS Team has recently attended the COST Action IMMUNO-model CA21135 annual conference in Warsaw, Poland (13th-14th May 2025). The initiative aims to foster research and innovation in the field of preclinical immuno-oncology models, advancing cancer treatment for patients by improving their outcomes and quality of life. IMMUNO-model brings together European researchers from diverse sectors (academia, clinical, industry) …
ICCVS Team at 3rd IMMUNO-model COST ACTION Annual Conference Read More »
CANVAS at INORMS 2025: Sharing insights and strengthening collaboration
We’re delighted that representatives of the CANVAS project had the opportunity to participate in the INORMS 2025 Congress in Madrid, hosted by EARMA – marking our second time at this global event. Engaging with peers from around the world, we explored key topics such as research impact, open science, AI tools, proposal development, leadership, and …
CANVAS at INORMS 2025: Sharing insights and strengthening collaboration Read More »
CANVAS Partners



